The current role of amphotericin B lipid complex in managing systemic fungal infections

By Chu Patrick   Sadullah Shalal  

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 3011-3020

Informa Healthcare

Access to resources Recommend Favorite

Safety and effectiveness of amphotericin B deoxycholate for the treatment of visceral leishmaniasis in Uganda

By Mueller Y.   Nguimfack A.   Cavailler P.   Couffignal S.   Rwakimari J. B.   Loutan L.   Chappuis F.  

Annals of Tropical Medicine and Parasitology, Vol. 102, Iss. 1, 2008-01 ,pp. : 11-19

Maney Publishing

Access to resources Recommend Favorite

Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin B-lipid complex

By Sundar S.   Goyal A. K.   More D. K.   Singh M. K.   Murray H. W.  

Annals of Tropical Medicine and Parasitology, Vol. 92, Iss. 7, 1998-10 ,pp. : 755-764

Routledge Ltd

Access to resources Recommend Favorite

Prospective audit of the effectiveness of hydrocortisone premedication on drug delivery reactions following amphotericin B lipid complex*

By O’Connor Nigel   Borley Ann  

Current Medical Research and Opinion, Vol. 25, Iss. 3, 2009-03 ,pp. : 749-754

Informa Healthcare

Access to resources Recommend Favorite

Should we continue using amphotericin B deoxycholate for the treatment of fungal infections? Adverse events and clinical outcomes

By Garbino Jorge   Markham Lydia   Matulionyte Raimonda   Rives Vincent   Lew Daniel  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 2, 2006-07 ,pp. : 110-113

Informa Healthcare

Access to resources Recommend Favorite